Results for “ ”

Entry Author Date Location
Wake Up, Pharma—Trump Is Not Your Savior 12/08/16 Boston
Should We Rewrite the Human Genome? 11/28/16 Boston
How to Lower Drug Prices, Improve Care, and Save Pharma 11/17/16 San Diego
Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine 11/04/16 Boston
The Power of the Cloud for Life Science R&D 10/19/16 Boston
Life Science Leaders Who Feel the Right Kind of Fear 10/12/16 Boston
How Doctors Think About Drug Prices 10/11/16 Boston
The XX Factor: Fixing Biotech’s Gender Imbalance in the C-Suite 08/29/16 San Francisco
Who’s to Blame for Inflated Health Insurance Costs? 08/24/16 Boston
Pharma’s Productivity Problem: Finding More Blockbuster Drugs 08/17/16 San Diego
Look Beyond Football to Fight Concussions 08/02/16 Boston
The Outbreaks Are Here, Where’s Our Response Plan? 07/25/16 Seattle
The Pan-Cancer Screen: Still Early for Prime Time 07/18/16 Boston
How to Make Healthcare Better? Make It Easy 06/08/16 Boston
More than a Matter of Appearances: Pharma’s Existential PR Problem 05/05/16 San Diego
A Vision for Boosting the Life Sciences in San Diego and Beyond 05/04/16 San Diego
Dear Biopharma: Give Us Better Therapies for Pain 03/23/16 Boston
FAST Act Offers More Goodies to Emerging Growth Companies 03/02/16 Boston
New York City: En Route to a Bio Cluster 02/29/16 New York
Realizing the Return on Digital Health Technologies 02/23/16 San Diego
Improving Odds for Women in Tech? Take Notes from Biotech 02/04/16 Boston
Time to Ease On Down the Road 02/03/16 Seattle
Always-on Health Care, Always-on Data 01/22/16 San Francisco
Oncology’s Future: Liquid Biopsies and the Heterogeneity of Cancer 01/05/16 San Diego
Lab Space on a Navy Ship, And Other Creative Solutions for NY Biotech 01/05/16 New York
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
The Scientist and the Student: Thoughts on Lessons Learned From a Mentor 12/24/15 National
Small Molecules: The Silent Majority of Pharmaceutical Pipelines 11/23/15 Boston
Selling Your Company? Don’t Make These Five Common Mistakes 10/15/15 Boston
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
Page 1 of 12 next page »